logologo
QuantliQuantli

Damora Therapeutics Inc

DMRA

NASDAQ

Biotechnology

$31.04

USD

+0.31 (+1.01%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $1.90B

Volume 260.7K

Price Target

$35.00$50.00

USD

The 3 analysts offering 1-year price forecasts have a max estimate of $50.00 and a min estimate of $35.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$43.33

+$0.3 vs prior

Implied Upside

+39.6%

+1.1% vs prior

Analyst Covering

3

+1 vs prior period

Consensus

Buy

Unchanged vs prior

Signal Quality

Consensus Freshness

60%

A mix of recent and older ratings shape this consensus

Analyst Agreement

Low

Targets are widely dispersed - limited agreement on price

Mean vs Median

$1.67 Gap

Median $45.00 vs avg $43.33 - a few cautious outliers are pulling the average down

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

3 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

3

Hold

0

Sell

0

Strong Sell

0

3 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Akash Tewari

Jefferies

Buy

Initiated

2 weeks ago

Plus
Plus
Plus

David Nierengarten

Wedbush

Buy

Reiterated

2 months ago

Plus
Plus
Plus

Mitchell S. Kapoor

HC Wainwright & Co.

Buy

Initiated

2 months ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

RXRX

Recursion Pharmaceuticals Inc

$3.16

-4.5%

AGIO

Agios Pharmaceuticals Inc

$33.56

+0.3%

ZBIO

Zenas Biopharma Inc

$29.51

+1.1%

STOK

Stoke Therapeutics Inc

$31.27

-0.1%

TSHA

Taysha Gene Therapies Inc

$5.95

-0.7%

SRPT

Sarepta Therapeutics Inc

$18.10

-1.7%

ANAB

AnaptysBio Inc

$58.47

+4.4%

SNDX

Syndax Pharmaceuticals Inc

$19.84

+4.0%

GENB

Generate Biomedicines Inc

$15.64

+4.1%